Exact Mass: 510.2663

Nebramycin factor 5

C19H38N6O10 (510.2649)

Physagulin A

C30H38O7 (510.2617)

Physagulin A is found in fruits. Physagulin A is a constituent of the famine food Physalis angulata (cutleaf ground cherry).

(2S,3S,4R)-4-(1,3-Benzodioxol-5-yl)-1-[2-(dibutylamino)-2-oxoethyl]-2-(4-methoxyphenyl)pyrrolidine-3-carboxylic acid

C29H38N2O6 (510.273)

PA(2:0/18:1(12Z)-2OH(9,10))

C23H43O10P (510.2594)

PA(2:0/18:1(12Z)-2OH(9,10)) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(2:0/18:1(12Z)-2OH(9,10)), in particular, consists of one chain of one acetyl at the C-1 position and one chain of 9,10-hydroxy-octadecenoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

PA(18:1(12Z)-2OH(9,10)/2:0)

C23H43O10P (510.2594)

PA(18:1(12Z)-2OH(9,10)/2:0) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(18:1(12Z)-2OH(9,10)/2:0), in particular, consists of one chain of one 9,10-hydroxy-octadecenoyl at the C-1 position and one chain of acetyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

Xanthobaccin A

C29H38N2O6 (510.273)

Schweinfurthin H

C30H38O7 (510.2617)

A stilbenoid isolated from Macaranga alnifolia and has been shwon to exhibit cytotoxic activity.

Longipedlactone G

C30H38O7 (510.2617)

Applanoxidic acid F

C30H38O7 (510.2617)

Kadlongilactone D

C30H38O7 (510.2617)

2-[(2R,4aS,8S,8aS)-8-[2-[(4aS,7R,8aR)-7-(1-carboxyethenyl)-1-hydroxy-4a-methyl-2-oxo-6,7,8,8a-tetrahydro-5H-naphthalen-1-yl]ethyl]-4a-methyl-7-oxo-1,2,3,4,8,8a-hexahydronaphthalen-2-yl]prop-2-enoic acid

C30H38O7 (510.2617)

Furanoganoderic acid

C30H38O7 (510.2617)

Nebramycin factor 13

C19H38N6O10 (510.2649)

C30H38O7

C30H38O7 (510.2617)

6alpha-acetoxy-14beta,15beta-epoxyazadirone

C30H38O7 (510.2617)

1-O-methyl-8-methoxy-8,8a-dihydrobractatin

C30H38O7 (510.2617)

maltophilin

C29H38N2O6 (510.273)

kadlongilactone F

C30H38O7 (510.2617)

Ruscogenin 1-O-sulfate

C27H42O7S (510.2651)

Alteramide A

C29H38N2O6 (510.273)

6beta-cinnamoyl--5alpha,7beta-dihydroxy-12,16-epoxy-12alpha-methoxycassa-13(15)-en-16-one|neocaesalpin G

C30H38O7 (510.2617)

6-oxopristimerol|Zeylasterone

C30H38O7 (510.2617)

11alpha-O-benzoyl-12beta-O-acetyltenacigenin B

C30H38O7 (510.2617)

schinchinenin D

C30H38O7 (510.2617)

16beta-acetoxy-6alpha,7alpha-epoxy-5alpha-hydroxy-1-oxowitha-2,17(20),24-trienolide

C30H38O7 (510.2617)

3a-hydroxy-8-methyl-1,2,3,3a,8,8a-hexahydro-pyrrolo[2,3-b]indole-2-carboxylic acid 2-acetoxy-8a-hydroxy-5-isopropenyl-3,8-dimethyl-1,2,4a,5,6,7,8,8a-octahydronaphthalen-1-yl ester|fischerindoline

C29H38N2O6 (510.273)

kaunial

C30H38O7 (510.2617)

pungiolide C

C30H38O7 (510.2617)

kadcoccilactone N

C30H38O7 (510.2617)

(E)-sarcodictyin B|sarcodictyin B

C29H38N2O6 (510.273)

5beta-myrtenyl-9alpha-hydroxy-4,5-dihydroatripliciolide-8-O-angelate

C30H38O7 (510.2617)

Nebramycin factor 11

C19H38N6O10 (510.2649)

Ganoderenic acid F

C30H38O7 (510.2617)

DEOXYGEDUNOL ACETATE

C30H38O7 (510.2617)

His Gln Ala Arg

C20H34N10O6 (510.2663)

Zeylasterone

C30H38O7 (510.2617)

Zeylasterone is a natural product found in Maytenus woodsonii, Kokoona reflexa, and Celastrus paniculatus with data available.

[3-methyl-1-[3-methyl-1-oxo-1-(2,3,4,5,6-pentahydroxyhexoxy)pentan-2-yl]oxy-1-oxobutan-2-yl] 2-hydroxy-3-methylpentanoate

C23H42O12 (510.2676)

[(2R,3S,4S,5R,6S)-3,4,5-trihydroxy-6-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]methyl 9-methyldecanoate

C23H42O12 (510.2676)

2-[(2R,4aS,8S,8aS)-8-[2-[(4aS,7R,8aR)-7-(1-carboxyethenyl)-1-hydroxy-4a-methyl-2-oxo-6,7,8,8a-tetrahydro-5H-naphthalen-1-yl]ethyl]-4a-methyl-7-oxo-1,2,3,4,8,8a-hexahydronaphthalen-2-yl]prop-2-enoic acid

C30H38O7 (510.2617)

Tobramycin 1-N- or 3-N-carbamoyl

C19H38N6O10 (510.2649)

Tobramycin 2 -N- or 6 -N-carbamoyl

C19H38N6O10 (510.2649)

[3-methyl-1-[3-methyl-1-oxo-1-(2,3,4,5,6-pentahydroxyhexoxy)pentan-2-yl]oxy-1-oxobutan-2-yl] 2-hydroxy-3-methylpentanoate [IIN-based: Match]

C23H42O12 (510.2676)

[3-methyl-1-[3-methyl-1-oxo-1-(2,3,4,5,6-pentahydroxyhexoxy)pentan-2-yl]oxy-1-oxobutan-2-yl] 2-hydroxy-3-methylpentanoate [IIN-based on: CCMSLIB00000847843]

C23H42O12 (510.2676)

2-[(2R,4aS,8S,8aS)-8-[2-[(4aS,7R,8aR)-7-(1-carboxyethenyl)-1-hydroxy-4a-methyl-2-oxo-6,7,8,8a-tetrahydro-5H-naphthalen-1-yl]ethyl]-4a-methyl-7-oxo-1,2,3,4,8,8a-hexahydronaphthalen-2-yl]prop-2-enoic acid [IIN-based on: CCMSLIB00000845468]

C30H38O7 (510.2617)

[(2R,3S,4S,5R,6S)-3,4,5-trihydroxy-6-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]methyl 9-methyldecanoate [IIN-based: Match]

C23H42O12 (510.2676)

2-[(2R,4aS,8S,8aS)-8-[2-[(4aS,7R,8aR)-7-(1-carboxyethenyl)-1-hydroxy-4a-methyl-2-oxo-6,7,8,8a-tetrahydro-5H-naphthalen-1-yl]ethyl]-4a-methyl-7-oxo-1,2,3,4,8,8a-hexahydronaphthalen-2-yl]prop-2-enoic acid [IIN-based: Match]

C30H38O7 (510.2617)

[(2R,3S,4S,5R,6S)-3,4,5-trihydroxy-6-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]methyl 9-methyldecanoate [IIN-based on: CCMSLIB00000847198]

C23H42O12 (510.2676)

Ala His Gln Arg

C20H34N10O6 (510.2663)

Ala His Arg Gln

C20H34N10O6 (510.2663)

Ala Gln His Arg

C20H34N10O6 (510.2663)

Ala Gln Arg His

C20H34N10O6 (510.2663)

Ala Arg His Gln

C20H34N10O6 (510.2663)

Ala Arg Gln His

C20H34N10O6 (510.2663)

His Ala Gln Arg

C20H34N10O6 (510.2663)

His Ala Arg Gln

C20H34N10O6 (510.2663)

His Gln Arg Ala

C20H34N10O6 (510.2663)

His Arg Ala Gln

C20H34N10O6 (510.2663)

His Arg Gln Ala

C20H34N10O6 (510.2663)

Gln Ala His Arg

C20H34N10O6 (510.2663)

Gln Ala Arg His

C20H34N10O6 (510.2663)

Gln His Ala Arg

C20H34N10O6 (510.2663)

Gln His Arg Ala

C20H34N10O6 (510.2663)

Gln Arg Ala His

C20H34N10O6 (510.2663)

Gln Arg His Ala

C20H34N10O6 (510.2663)

Arg Ala His Gln

C20H34N10O6 (510.2663)

Arg Ala Gln His

C20H34N10O6 (510.2663)

Arg His Ala Gln

C20H34N10O6 (510.2663)

Arg His Gln Ala

C20H34N10O6 (510.2663)

Arg Gln Ala His

C20H34N10O6 (510.2663)

Arg Gln His Ala

C20H34N10O6 (510.2663)

Physagulin A

C30H38O7 (510.2617)

PS-PA

C23H43O10P (510.2594)

Fmoc-L-Lys(Boc,iPr)-OH

C29H38N2O6 (510.273)

Atrasentan

C29H38N2O6 (510.273)

C28313 - Endothelin Receptor Antagonist > C28334 - Endothelin Receptor Type A Antagonist D065128 - Endothelin Receptor Antagonists > D065130 - Endothelin A Receptor Antagonists D000970 - Antineoplastic Agents

Bis(tri-t-butylphosphine)palladium

C24H54P2Pd (510.2735)

Imatinib (Pyridine)-N-Oxide

C29H32N7O2- (510.2617)

1,2-BIS[BIS(3,5-DIMETHYLPHENYL)PHOSPHINO]ETHANE

C34H40P2 (510.2605)

(2S,3S,4R)-4-(1,3-Benzodioxol-5-yl)-1-[2-(dibutylamino)-2-oxoethyl]-2-(4-methoxyphenyl)pyrrolidine-3-carboxylic acid

C29H38N2O6 (510.273)

PA(2:0/18:1(12Z)-2OH(9,10))

C23H43O10P (510.2594)

PA(18:1(12Z)-2OH(9,10)/2:0)

C23H43O10P (510.2594)

N-[[(8R,9R)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-9-yl]methyl]-N-methyl-5-phenyl-3-isoxazolecarboxamide

C26H34N6O5 (510.2591)

N-[[(8R,9R)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-9-yl]methyl]-N-methyl-5-phenyl-3-isoxazolecarboxamide

C26H34N6O5 (510.2591)

N-[[(8S,9S)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-9-yl]methyl]-N-methyl-5-phenyl-3-isoxazolecarboxamide

C26H34N6O5 (510.2591)

N-[[(8R,9R)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-9-yl]methyl]-N-methyl-5-phenyl-3-isoxazolecarboxamide

C26H34N6O5 (510.2591)

N-[[(8R,9S)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-9-yl]methyl]-N-methyl-5-phenyl-3-isoxazolecarboxamide

C26H34N6O5 (510.2591)

N-[[(8S,9S)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-9-yl]methyl]-N-methyl-5-phenyl-3-isoxazolecarboxamide

C26H34N6O5 (510.2591)

N-[[(8S,9R)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-9-yl]methyl]-N-methyl-5-phenyl-3-isoxazolecarboxamide

C26H34N6O5 (510.2591)

N-[[(8S,9R)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-9-yl]methyl]-N-methyl-5-phenyl-3-isoxazolecarboxamide

C26H34N6O5 (510.2591)

N-[[(8S,9S)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-9-yl]methyl]-N-methyl-5-phenyl-3-isoxazolecarboxamide

C26H34N6O5 (510.2591)

N-[[(8R,9R)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-9-yl]methyl]-N-methyl-5-phenyl-3-isoxazolecarboxamide

C26H34N6O5 (510.2591)

N-[[(8R,9S)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-9-yl]methyl]-N-methyl-5-phenyl-3-isoxazolecarboxamide

C26H34N6O5 (510.2591)

N-[[(8S,9R)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-9-yl]methyl]-N-methyl-5-phenyl-3-isoxazolecarboxamide

C26H34N6O5 (510.2591)

N-[[(8R,9S)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-9-yl]methyl]-N-methyl-5-phenyl-3-isoxazolecarboxamide

C26H34N6O5 (510.2591)

N-[[(8S,9R)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-9-yl]methyl]-N-methyl-5-phenyl-3-isoxazolecarboxamide

C26H34N6O5 (510.2591)

N-[[(8R,9S)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-9-yl]methyl]-N-methyl-5-phenyl-3-isoxazolecarboxamide

C26H34N6O5 (510.2591)

[3-Methyl-1-[3-methyl-1-oxo-1-(2,3,4,5,6-pentahydroxyhexoxy)pentan-2-yl]oxy-1-oxobutan-2-yl] 2-hydroxy-3-methylpentanoate

C23H42O12 (510.2676)

N-[[(8S,9S)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-9-yl]methyl]-N-methyl-5-phenyl-3-isoxazolecarboxamide

C26H34N6O5 (510.2591)

[(2R,3S,4S,5R,6S)-3,4,5-Trihydroxy-6-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]methyl 9-methyldecanoate

C23H42O12 (510.2676)

methyl 6-O-[15-(ethyldisulfanyl)pentadecanoyl]-beta-D-galactoside

C24H46O7S2 (510.2685)

Tobramycin 1-N-or 3-N-carbamoyl

C19H38N6O10 (510.2649)

[1-hydroxy-3-[hydroxy-(3-hydroxy-2-propanoyloxypropoxy)phosphoryl]oxypropan-2-yl] (Z)-tetradec-9-enoate

C23H43O10P (510.2594)

[1-[(2-butanoyloxy-3-hydroxypropoxy)-hydroxyphosphoryl]oxy-3-hydroxypropan-2-yl] (Z)-tridec-9-enoate

C23H43O10P (510.2594)

[1-[(2-acetyloxy-3-hydroxypropoxy)-hydroxyphosphoryl]oxy-3-hydroxypropan-2-yl] (Z)-pentadec-9-enoate

C23H43O10P (510.2594)

[1-butanoyloxy-3-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxypropan-2-yl] (Z)-tridec-9-enoate

C23H43O10P (510.2594)

[1-acetyloxy-3-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxypropan-2-yl] (Z)-pentadec-9-enoate

C23H43O10P (510.2594)

[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-propanoyloxypropan-2-yl] (Z)-tetradec-9-enoate

C23H43O10P (510.2594)

6-O-Carbamoyltobramycin

C19H38N6O10 (510.2649)

1-palmitoyl-2-succinyl-sn-glycero-3-phosphate

C23H43O10P (510.2594)

nebramycin 5

C19H38N6O10 (510.2649)

A carbamoylkanamycin that is tobramycin bearing a single carbamoyl substituent located at position 6 (on the 3-aminoglucose ring).

LPA 24:6

C27H43O7P (510.2746)

PA 16:0/4:1;O2

C23H43O10P (510.2594)

PG 13:0/4:1

C23H43O10P (510.2594)

PG 15:1/2:0

C23H43O10P (510.2594)

PG 17:1

C23H43O10P (510.2594)

PG 2:0_15:1

C23H43O10P (510.2594)

LPEth 22:6

C27H43O7P (510.2746)

LPM 23:6

C27H43O7P (510.2746)

ST 24:6;O;GlcA

C30H38O7 (510.2617)

ST 27:3;O4;S

C27H42O7S (510.2651)

(1s,2r,4r,6s,7s,10r,11r,16r,17r,18s)-18-(acetyloxy)-6-(furan-3-yl)-1,7,11,15,15-pentamethyl-14-oxo-3-oxapentacyclo[8.8.0.0²,⁴.0²,⁷.0¹¹,¹⁶]octadec-12-en-17-yl acetate

C30H38O7 (510.2617)

(2s,5z)-2-methyl-4-oxo-6-[(1r,3r,5s,10s,14r,15r,18r)-6,6,10,14,18-pentamethyl-7,13,17-trioxo-2-oxapentacyclo[9.7.0.0¹,³.0⁵,¹⁰.0¹⁴,¹⁸]octadec-11-en-15-yl]hept-5-enoic acid

C30H38O7 (510.2617)

(6bs,8as,11r,12ar,12bs,14ar)-2,3-dihydroxy-11-(methoxycarbonyl)-6b,8a,11,12b,14a-pentamethyl-5-oxo-7,8,9,10,12,12a,13,14-octahydropicene-4-carboxylic acid

C30H38O7 (510.2617)

(1s,2r,7s,9r,11r,12r,13s,16r)-15-[(1s)-1-[(2r)-4,5-dimethyl-6-oxo-2,3-dihydropyran-2-yl]ethyl]-12-hydroxy-2,16-dimethyl-3-oxo-8-oxapentacyclo[9.7.0.0²,⁷.0⁷,⁹.0¹²,¹⁶]octadeca-4,14-dien-13-yl acetate

C30H38O7 (510.2617)

(1r,2r,4s,10s,11r,13s,14r,19r)-1,11-dihydroxy-9,9,14-trimethyl-17-[(1r)-1-[(2r)-5-methyl-6-oxo-2,3-dihydropyran-2-yl]ethyl]-18-methylidene-3,8-dioxapentacyclo[11.7.0.0²,⁴.0⁴,¹⁰.0¹⁴,¹⁹]icosa-5,16-dien-7-one

C30H38O7 (510.2617)

3-(4-{3-hydroxy-3a,6,6,9a,11a-pentamethyl-4,7,10-trioxo-1h,2h,3h,5h,5ah,8h,9h,11h-cyclopenta[a]phenanthren-1-yl}furan-2-yl)-2-methylpropanoic acid

C30H38O7 (510.2617)

(3e,5e,7s,8r,10s,15r,16z,18z,24s)-11-ethyl-7,20,24,27,28-pentahydroxy-10-methyl-21,26-diazatetracyclo[23.2.1.0⁸,¹⁵.0⁹,¹³]octacosa-1(28),3,5,16,18,20,26-heptaen-2-one

C29H38N2O6 (510.273)

(1e,3z,5z,7s,8r,9s,10s,11s,13r,15s,16z,18z,24s,25s)-11-ethyl-2,7,20,24,27-pentahydroxy-10-methyl-21,26-diazatetracyclo[23.2.1.0⁸,¹⁵.0⁹,¹³]octacosa-1,3,5,16,18,20,26-heptaen-28-one

C29H38N2O6 (510.273)

methyl (2s,4as,6ar,12br,14as,14br)-9-formyl-10,11-dihydroxy-2,4a,6a,12b,14a-pentamethyl-3,8-dioxo-4,5,6,6b,7,13,14,14b-octahydro-1h-picene-2-carboxylate

C30H38O7 (510.2617)

applanoxidic acid F

C30H38O7 (510.2617)

{"Ingredient_id": "HBIN016523","Ingredient_name": "applanoxidic acid F","Alias": "NA","Ingredient_formula": "C30H38O7","Ingredient_Smile": "CC(CC(=O)C=C(C)C1CC(=O)C2(C1(C(=O)C=C3C24C(O4)CC5C3(CCC(=O)C5(C)C)C)C)C)C(=O)O","Ingredient_weight": "510.6 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "38765","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "101664507","DrugBank_id": "NA"}

(1s,2r,4r,12r,15s,16s,18r,19r,20r,21s,26s)-4,18-dihydroxy-11,11,16,20,24-pentamethyl-10,22,28-trioxaheptacyclo[17.8.1.0¹,¹⁹.0²,¹⁶.0⁴,¹⁵.0⁶,¹².0²¹,²⁶]octacosa-5,7,24-triene-9,23-dione

C30H38O7 (510.2617)

(3e,5s,6r,8r,9r,10s,11s,12s,14r,16s,17e,19e)-12-ethyl-2,5,21,28-tetrahydroxy-11-methyl-7-oxa-22,27-diazapentacyclo[24.2.1.0⁶,⁸.0⁹,¹⁶.0¹⁰,¹⁴]nonacosa-1,3,17,19,21,27-hexaen-29-one

C29H38N2O6 (510.273)

(3e,18z)-11-ethyl-2,20,24,27-tetrahydroxy-10-methyl-21,26-diazapentacyclo[23.2.1.0⁵,¹⁶.0⁸,¹⁵.0⁹,¹³]octacosa-1,3,18,20,26-pentaene-7,28-dione

C29H38N2O6 (510.273)

(5z)-6-[(1r,3ar,5ar,9as,11ar)-3a,6,6,9a,11a-pentamethyl-3,4,7,10-tetraoxo-1h,2h,5h,5ah,8h,9h,11h-cyclopenta[a]phenanthren-1-yl]-2-methyl-4-oxohept-5-enoic acid

C30H38O7 (510.2617)

6-{3a,6,6,9a,11a-pentamethyl-3,7,11-trioxo-5h,5ah,8h,9h-cyclopenta[a]phenanthren-1-yl}-6-hydroxy-2-methyl-4-oxoheptanoic acid

C30H38O7 (510.2617)

(3e,5r,8s,9s,10r,11s,13s,15r,16r,18z,24r,25r)-11-ethyl-20,24,27,28-tetrahydroxy-10-methyl-21,26-diazapentacyclo[23.2.1.0⁵,¹⁶.0⁸,¹⁵.0⁹,¹³]octacosa-1(28),3,18,20,26-pentaene-2,7-dione

C29H38N2O6 (510.273)

17-(acetyloxy)-6-(furan-3-yl)-1,7,11,15,15-pentamethyl-14-oxo-3-oxapentacyclo[8.8.0.0²,⁴.0²,⁷.0¹¹,¹⁶]octadec-12-en-18-yl acetate

C30H38O7 (510.2617)

2,3-dihydroxy-11-(methoxycarbonyl)-6b,8a,11,12b,14a-pentamethyl-5-oxo-7,8,9,10,12,12a,13,14-octahydropicene-4-carboxylic acid

C30H38O7 (510.2617)

(2s,5e)-6-[(1s,3s,5r,10s,14r,17r,18s)-17-hydroxy-6,6,10,14,18-pentamethyl-7,13-dioxo-2-oxapentacyclo[9.7.0.0¹,³.0⁵,¹⁰.0¹⁴,¹⁸]octadeca-11,15-dien-15-yl]-2-methyl-4-oxohept-5-enoic acid

C30H38O7 (510.2617)

(5z)-2-methyl-4-oxo-6-[(1r,3r,5r,10s,14r,15r,18r)-6,6,10,14,18-pentamethyl-7,13,17-trioxo-2-oxapentacyclo[9.7.0.0¹,³.0⁵,¹⁰.0¹⁴,¹⁸]octadec-11-en-15-yl]hept-5-enoic acid

C30H38O7 (510.2617)

(3e,5r,8s,9r,10r,13s,15s,16r,18z,24s,25s)-11-ethyl-2,20,24,27-tetrahydroxy-10-methyl-21,26-diazapentacyclo[23.2.1.0⁵,¹⁶.0⁸,¹⁵.0⁹,¹³]octacosa-1,3,18,20,26-pentaene-7,28-dione

C29H38N2O6 (510.273)

(1r,2r,4r,10s,11r,13s,14r,19r)-1,11-dihydroxy-9,9,14-trimethyl-17-[(1r)-1-[(2r)-5-methyl-6-oxo-2,3-dihydropyran-2-yl]ethyl]-18-methylidene-3,8-dioxapentacyclo[11.7.0.0²,⁴.0⁴,¹⁰.0¹⁴,¹⁹]icosa-5,16-dien-7-one

C30H38O7 (510.2617)

(1s,2s,4s,5r,10r,11s,14s,15z,16s,18s)-15-{1-[(2r)-4,5-dimethyl-6-oxo-2,3-dihydropyran-2-yl]ethylidene}-5-hydroxy-10,14-dimethyl-9-oxo-3-oxapentacyclo[9.7.0.0²,⁴.0⁵,¹⁰.0¹⁴,¹⁸]octadec-7-en-16-yl acetate

C30H38O7 (510.2617)

(1s,2r,4ar,5r,8r,8ar)-2-(acetyloxy)-8a-hydroxy-3,8-dimethyl-5-(prop-1-en-2-yl)-2,4a,5,6,7,8-hexahydro-1h-naphthalen-1-yl (2s,3ar,8ar)-3a-hydroxy-8-methyl-1h,2h,3h,8ah-pyrrolo[2,3-b]indole-2-carboxylate

C29H38N2O6 (510.273)

(3e,5r,8s,9r,10r,11s,13s,15s,16r,18z,24s,25s)-11-ethyl-20,24,27,28-tetrahydroxy-10-methyl-21,26-diazapentacyclo[23.2.1.0⁵,¹⁶.0⁸,¹⁵.0⁹,¹³]octacosa-1(28),3,18,20,26-pentaene-2,7-dione

C29H38N2O6 (510.273)

ethyl (1r,2e,4s,5r,9r,11s,12s)-1-hydroxy-5-isopropyl-8,12-dimethyl-11-{[(2e)-3-(1-methylimidazol-4-yl)prop-2-enoyl]oxy}-15-oxatricyclo[10.2.1.0⁴,⁹]pentadeca-2,7,13-triene-2-carboxylate

C29H38N2O6 (510.273)

(1e,3z,5r,8s,9s,10s,11s,13r,15r,16r,18z)-11-ethyl-2,20,24,27-tetrahydroxy-10-methyl-21,26-diazapentacyclo[23.2.1.0⁵,¹⁶.0⁸,¹⁵.0⁹,¹³]octacosa-1,3,18,20,26-pentaene-7,28-dione

C29H38N2O6 (510.273)

11-ethyl-7,24,27,28-tetrahydroxy-10-methyl-21,26-diazatetracyclo[23.2.1.0⁸,¹⁵.0⁹,¹³]octacosa-1(28),3,5,16,18,26-hexaene-2,20-dione

C29H38N2O6 (510.273)

(4ar,5r,6r,6as,7r,10ar,11as,11br)-4a,6-dihydroxy-10a-methoxy-4,4,7,11b-tetramethyl-9-oxo-1h,2h,3h,5h,6h,6ah,7h,11h,11ah-phenanthro[3,2-b]furan-5-yl (2e)-3-phenylprop-2-enoate

C30H38O7 (510.2617)

(2r,3s,4s,8s,9s,10r,11r)-3-{[(1s,5r)-6,6-dimethylbicyclo[3.1.1]hept-2-en-2-yl]methyl}-10-hydroxy-2,11-dimethyl-7-methylidene-6,12-dioxo-5,14-dioxatricyclo[9.2.1.0⁴,⁸]tetradec-1(13)-en-9-yl (2z)-2-methylbut-2-enoate

C30H38O7 (510.2617)

(1s,3ar,3bs,7s,9ar,11r,11as)-1-acetyl-1,3a,3b,7-tetrahydroxy-9a,11a-dimethyl-2h,3h,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-11-yl (2e)-3-phenylprop-2-enoate

C30H38O7 (510.2617)

4a,6-dihydroxy-10a-methoxy-4,4,7,11b-tetramethyl-9-oxo-1h,2h,3h,5h,6h,6ah,7h,11h,11ah-phenanthro[3,2-b]furan-5-yl 3-phenylprop-2-enoate

C30H38O7 (510.2617)

(1r,2s,5s,11s,13r,14r,16r,19s,24r,25s,27r)-14,27-dihydroxy-1,6,6,21,25-pentamethyl-7,12,23-trioxaheptacyclo[14.12.0.0²,¹⁴.0⁵,¹¹.0¹¹,¹³.0¹⁷,²⁶.0¹⁹,²⁴]octacosa-9,17(26),20-triene-8,22-dione

C30H38O7 (510.2617)

(15z)-15-[1-(4,5-dimethyl-6-oxo-2,3-dihydropyran-2-yl)ethylidene]-5-hydroxy-10,14-dimethyl-9-oxo-3-oxapentacyclo[9.7.0.0²,⁴.0⁵,¹⁰.0¹⁴,¹⁸]octadec-7-en-16-yl acetate

C30H38O7 (510.2617)

(3e,5r,8s,9s,10r,13s,15s,16r,18z,25s)-11-ethyl-2,9,20,27-tetrahydroxy-10-methyl-21,26-diazapentacyclo[23.2.1.0⁵,¹⁶.0⁸,¹⁵.0⁹,¹³]octacosa-1,3,18,20,26-pentaene-7,28-dione

C29H38N2O6 (510.273)

(1s,2r,4r,6s,7s,10r,11r,17r,18s)-18-(acetyloxy)-6-(furan-3-yl)-1,7,11,15,15-pentamethyl-14-oxo-3-oxapentacyclo[8.8.0.0²,⁴.0²,⁷.0¹¹,¹⁶]octadec-12-en-17-yl acetate

C30H38O7 (510.2617)

7-[2-(3,5-dihydroxy-2,2-dimethyl-3,4-dihydro-1-benzopyran-7-yl)ethenyl]-5-methoxy-1,1,4a-trimethyl-3,4,9,9a-tetrahydro-2h-xanthene-2,3-diol

C30H38O7 (510.2617)

(1e,3z,5z,7s,8r,9s,10s,11s,13r,15r,16z,18z,24s,25s)-11-ethyl-2,7,20,24,27-pentahydroxy-10-methyl-21,26-diazatetracyclo[23.2.1.0⁸,¹⁵.0⁹,¹³]octacosa-1,3,5,16,18,20,26-heptaen-28-one

C29H38N2O6 (510.273)

1,11-dihydroxy-9,9,14-trimethyl-17-[1-(5-methyl-6-oxo-2,3-dihydropyran-2-yl)ethyl]-18-methylidene-3,8-dioxapentacyclo[11.7.0.0²,⁴.0⁴,¹⁰.0¹⁴,¹⁹]icosa-5,16-dien-7-one

C30H38O7 (510.2617)

(2s,3r,4ar,9ar)-7-[(1e)-2-[(3s)-3,5-dihydroxy-2,2-dimethyl-3,4-dihydro-1-benzopyran-7-yl]ethenyl]-5-methoxy-1,1,4a-trimethyl-3,4,9,9a-tetrahydro-2h-xanthene-2,3-diol

C30H38O7 (510.2617)

1-acetyl-1,3a,3b,7-tetrahydroxy-9a,11a-dimethyl-2h,3h,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-11-yl 3-phenylprop-2-enoate

C30H38O7 (510.2617)

(3e,5r,8s,9s,10r,11s,13s,15s,16r,18z,25s)-11-ethyl-9,20,27,28-tetrahydroxy-10-methyl-21,26-diazapentacyclo[23.2.1.0⁵,¹⁶.0⁸,¹⁵.0⁹,¹³]octacosa-1(28),3,18,20,26-pentaene-2,7-dione

C29H38N2O6 (510.273)

14,27-dihydroxy-1,6,6,21,25-pentamethyl-7,12,23-trioxaheptacyclo[14.12.0.0²,¹⁴.0⁵,¹¹.0¹¹,¹³.0¹⁷,²⁶.0¹⁹,²⁴]octacosa-9,17(26),20-triene-8,22-dione

C30H38O7 (510.2617)

(2s,5e)-6-[(1r,3ar,5ar,9as,11ar)-3a,6,6,9a,11a-pentamethyl-3,4,7,10-tetraoxo-1h,2h,5h,5ah,8h,9h,11h-cyclopenta[a]phenanthren-1-yl]-2-methyl-4-oxohept-5-enoic acid

C30H38O7 (510.2617)

6-{3a,6,6,9a,11a-pentamethyl-3,4,7,10-tetraoxo-1h,2h,5h,5ah,8h,9h,11h-cyclopenta[a]phenanthren-1-yl}-2-methyl-4-oxohept-5-enoic acid

C30H38O7 (510.2617)

11-ethyl-2,20,24,27-tetrahydroxy-10-methyl-21,26-diazapentacyclo[23.2.1.0⁵,¹⁶.0⁸,¹⁵.0⁹,¹³]octacosa-1,3,18,20,26-pentaene-7,28-dione

C29H38N2O6 (510.273)

3-({6,6-dimethylbicyclo[3.1.1]hept-2-en-2-yl}methyl)-10-hydroxy-2,11-dimethyl-7-methylidene-6,12-dioxo-5,14-dioxatricyclo[9.2.1.0⁴,⁸]tetradec-1(13)-en-9-yl 2-methylbut-2-enoate

C30H38O7 (510.2617)

(2s,3r,4ar,9ar)-7-[(1e)-2-[(3r)-3,5-dihydroxy-2,2-dimethyl-3,4-dihydro-1-benzopyran-7-yl]ethenyl]-5-methoxy-1,1,4a-trimethyl-3,4,9,9a-tetrahydro-2h-xanthene-2,3-diol

C30H38O7 (510.2617)

(1r,3ar,3bs,7s,9ar,9br,11r,11as)-1-acetyl-1,3a,3b,7-tetrahydroxy-9a,11a-dimethyl-2h,3h,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-11-yl (2e)-3-phenylprop-2-enoate

C30H38O7 (510.2617)

(3e,5e,7s,8r,9s,10s,11s,13r,15s,16e,18e,24s,25s)-11-ethyl-7,20,24,27,28-pentahydroxy-10-methyl-21,26-diazatetracyclo[23.2.1.0⁸,¹⁵.0⁹,¹³]octacosa-1(28),3,5,16,18,20,26-heptaen-2-one

C29H38N2O6 (510.273)

(1s,3ar,3bs,7s,9ar,9br,11r,11as)-1-acetyl-1,3a,3b,7-tetrahydroxy-9a,11a-dimethyl-2h,3h,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-11-yl (2e)-3-phenylprop-2-enoate

C30H38O7 (510.2617)

(3e,5e,8s,9s,10s,11s,13r,15s,16e,18e,25s)-2,11,20,27-tetrahydroxy-11-(1-hydroxyethyl)-10-methyl-21,26-diazatetracyclo[23.2.1.0⁸,¹⁵.0⁹,¹³]octacosa-1,3,5,16,18,20,26-heptaen-28-one

C29H38N2O6 (510.273)

12'-acetyl-10'-hydroxy-7,9'-dimethyl-4'-methylidene-6-(3-oxobutyl)-4,7,8,8a-tetrahydro-3ah-6'-oxaspiro[cyclohepta[b]furan-3,13'-tricyclo[8.4.0.0³,⁷]tetradecan]-11'-ene-2,5'-dione

C30H38O7 (510.2617)

(1's,3r,3'r,3as,7r,7'r,8as,9's,10's)-12'-acetyl-10'-hydroxy-7,9'-dimethyl-4'-methylidene-6-(3-oxobutyl)-4,7,8,8a-tetrahydro-3ah-6'-oxaspiro[cyclohepta[b]furan-3,13'-tricyclo[8.4.0.0³,⁷]tetradecan]-11'-ene-2,5'-dione

C30H38O7 (510.2617)

6-[(3as,5ar,9as,11ar)-3a,6,6,9a,11a-pentamethyl-3,7,11-trioxo-5h,5ah,8h,9h-cyclopenta[a]phenanthren-1-yl]-6-hydroxy-2-methyl-4-oxoheptanoic acid

C30H38O7 (510.2617)

(2s)-3-{4-[(1s,3s,3ar,5ar,9as,11ar)-3-hydroxy-3a,6,6,9a,11a-pentamethyl-4,7,10-trioxo-1h,2h,3h,5h,5ah,8h,9h,11h-cyclopenta[a]phenanthren-1-yl]furan-2-yl}-2-methylpropanoic acid

C30H38O7 (510.2617)

(3e,5s,7s,8r,9s,10s,11r,13r,15r,16s,18z)-11-ethenyl-2,7,20,24,27-pentahydroxy-10-methyl-21,26-diazapentacyclo[23.2.1.0⁵,¹⁶.0⁸,¹⁵.0⁹,¹³]octacosa-1,3,18,20,26-pentaen-28-one

C29H38N2O6 (510.273)

2-(acetyloxy)-8a-hydroxy-3,8-dimethyl-5-(prop-1-en-2-yl)-2,4a,5,6,7,8-hexahydro-1h-naphthalen-1-yl 3a-hydroxy-8-methyl-1h,2h,3h,8ah-pyrrolo[2,3-b]indole-2-carboxylate

C29H38N2O6 (510.273)

(1e,3e,18z)-11-ethyl-2,20,24,27-tetrahydroxy-10-methyl-21,26-diazapentacyclo[23.2.1.0⁵,¹⁶.0⁸,¹⁵.0⁹,¹³]octacosa-1,3,18,20,26-pentaene-7,28-dione

C29H38N2O6 (510.273)

2-methyl-4-oxo-6-{6,6,10,14,18-pentamethyl-7,13,17-trioxo-2-oxapentacyclo[9.7.0.0¹,³.0⁵,¹⁰.0¹⁴,¹⁸]octadec-11-en-15-yl}hept-5-enoic acid

C30H38O7 (510.2617)

(5e)-2-methyl-4-oxo-6-[(1r,3r,5r,10s,14r,15r,18r)-6,6,10,14,18-pentamethyl-7,13,17-trioxo-2-oxapentacyclo[9.7.0.0¹,³.0⁵,¹⁰.0¹⁴,¹⁸]octadec-11-en-15-yl]hept-5-enoic acid

C30H38O7 (510.2617)